Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
518 trades
$10.3T in total
Open-market sales
1,246 trades
$1.4B in total
Insiders filing
582 insiders
Last 7 days
Trade type
Ernexa TherapeuticsERNA
Open-market buy02/1002/174,000,000 sh$0.50$2,000,000+143.9%
Ernexa TherapeuticsERNA
Open-market buy25/06/0925/06/1121,241,163 sh$0.10$2,124,116.3+104.0%
10% Owner
Ernexa TherapeuticsERNA
Open-market buyAmendment24/09/2425/05/0713,252,112 sh5 tradesNo stated valueNo stated value+2381.5%
Ernexa TherapeuticsERNA
Open-market buy25/04/0225/04/043,768,397 sh$0.10$376,839.7+22.7%
10% Owner
Ernexa TherapeuticsERNA
Open-market buy24/10/2924/11/0513,252,112 sh5 tradesNo stated valueNo stated value+2381.5%